Purchase Order 36C24823P0226

Award Date 11/16/22
Potential Completion Date 11/30/22
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $31,018.03 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the emergency supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. Cardinal Health 414 is a subsidiary of the global healthcare services company Cardinal Health, Inc. and specializes in providing radiopharmaceuticals and related products to federal agencies, including the VA, Department of Defense, and National...
This federal contract award is for the delivery of the radiopharmaceutical Xofigo (radium-223 dichloride) to the Veterans Integrated Service Network 8, which is a division of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. that specializes in radiopharmaceuticals and other nuclear medicine products. The contract has a ceiling value of $12,908.77 and was awarded on October 1, 2021 with an ultimate completion...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of Xofigo (radium-223 dichloride), a radiopharmaceutical therapy for prostate cancer treatment. The contract has a ceiling value of $110,610.65 and a period of performance ending on February 28, 2025. Cardinal Health 414, LLC is a prominent supplier of...
This federal contract award, valued at $261,303.00, was issued by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the supply of the radiopharmaceutical product Xofigo (radium-223 dichloride). The contract is a firm fixed-price purchase order with an ultimate completion date of April 11, 2026. Cardinal Health 414, LLC is a subsidiary of the larger Cardinal Health, Inc., a global healthcare services company that...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $109,948.16 firm fixed price contract is for the delivery of the radiopharmaceutical product Xofigo Radium Ra 223 Dichloride. The contract, which has a completion date of March 31, 2021, was not set aside for any specific business type. Cardinal Health 414 holds several indefinite delivery vehicles (IDVs) to provide...
This federal contract award is for the delivery of RADIUM 223 XOFIGO, a radiopharmaceutical product, to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 17. The contract was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract has a potential value of $382,864.08 and is a firm fixed price delivery order with no set-aside designation. Cardinal Health 414 has provided...
This is a firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the radiopharmaceutical Xofigo, used in the treatment of prostate cancer. The contract has a potential value of $12,970.58 and a completion date of February 10, 2023. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and other...
This firm fixed-price purchase order contract was awarded by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $64,325.92 and is for the delivery of the radiopharmaceutical Xofigo (radium-223 dichloride) to support nuclear medicine and oncology services for the VA healthcare system. The contract has an ultimate completion date of...
This federal contract award to Cardinal Health 414, LLC was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The $270,000.00 firm fixed price delivery order is for the radiopharmaceutical product Xofigo Radium 223. The contract has a completion date of February 1, 2019. Cardinal Health 414 is a subsidiary of the global healthcare services company Cardinal Health, Inc. and has previously delivered radiopharmaceuticals, diagnostic imaging agents, and other...
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $1,476,887.19 firm fixed price delivery order is for the supply of Xofigo, a radiopharmaceutical treatment for cancer. The contract has a performance period through May 31, 2019 and did not utilize any set-aside designation. Cardinal Health 414 has multiple indefinite delivery contracts with the VA to provide...

This federal contract award, valued at $12,623.78, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of Xofigo (radium-223 dichloride), a radiopharmaceutical therapy used to treat prostate cancer.

Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and related products to federal healthcare agencies including the VA, Department of Defense, and National Institutes of Health. The company holds numerous Indefinite Delivery Vehicles (IDVs) with the VA, valued from $1 million to $39.8 million, that provide ongoing supply of these specialized products to VA medical centers nationwide. This specific award does not have a set-aside designation and is a firm fixed-price purchase order with a completion date of November 30, 2022.

Generated 7/16/24, 12:35 PM